Press release
SMi’ 10th Annual Social Media in Pharma – Pfizer Exclusive Speaker Interview
SMi are delighted to welcome Sarah Holiday, Social Media Strategy Lead, Pfizer onto the speaker panel!Sarah has worked in the pharmaceutical industry for 20 years in a variety of sales, customer access, training and marketing roles and ran the first ever disease awareness YouTube campaign with YouTube vloggers in Pfizer.
Having made the transition from UK country brand leader to Pfizer’s regional digital marketing team in 2016 to support a brand, Sarah then moved into her current role of Social Media Strategy Lead for Europe and Developed Asia in April 2017. In this role Sarah works with a variety of stakeholders to ensure Pfizer has the appropriate framework and processes to effectively and compliantly utilise social media as a marketing and communications channel and supports brand teams with content and channel development to optimise audience engagement.
Sarahs presentation: ‘Building integrated, impactful social media strategies which engage HCPs and patients as part of the multi-channel mix.’ Day 2 | @15:10
Summary of presentation:
- How can pharma brands integrate and adapt social media for greater levels of impact and relevancy as part of the wider digital and multi-channel mix?
- What’s the right platform for your brand?
- From global to local markets, advice on building an integrated social media strategy which maximises brand impact
SMi had the chance to interview Sarah about her experience in the industry, here’s one of her answers:
"Patient engagement is really important – we want to be able to talk and listen to people so we can meet their needs. We’re not always brilliant at doing this we are trying to improve and lose the anxiety we have about two-way communication. Pfizer use a tool called Sprinklr that helps manage social channels in one place – to publish, listen and monitor and moderate comments all in one place."
View the full interview in the download centre online. www.social-media-pharma.com/opr
- Here Are Some Featured Highlights This Jan:
- Hear how Janssen create powerful pharmaceutical social media strategies enabling patient engagement.
- Learn how to build integrated, impactful social media strategies with Pfizer.
- Discuss the potential of wearable technologies creating behavioural changes for patients with UCB.
- Discover with GSK how to make your social media content less “promotional” and more about storytelling.
- Examine how Bristol Myers-Squibb create an excellent digital strategy whilst engaging patients.
For more information on all sessions, view the full agenda: www.social-media-pharma.com/opr
For those looking to attend there is currently a £100 early-bird saving by November 30th.
SMi Presents the 10th Annual Conference:
Social Media in the Pharmaceutical Industry
Date: 22nd – 23rd January 2017
Location: Kensington, London
Website: www.social-media-pharma.com/opr
---end---
Contact Information:
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Westminster Bridge Road
1
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SMi’ 10th Annual Social Media in Pharma – Pfizer Exclusive Speaker Interview here
News-ID: 833316 • Views: …
More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK.
The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines.
Darren Green, Director of Computational Chemistry at GSK will be chairing at…

Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety.
SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA.
The 2022 Conference theme is…

SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022.
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering…

Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.
Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022.
This event will convene on February 9th – 10th 2022,…
More Releases for Pfizer
Oligodendroglioma Market to Witness Growth by 2032 | Companies- EpicentRx, Pfize …
DelveInsight's "Oligodendroglioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Oligodendroglioma, historical and forecasted epidemiology as well as the Oligodendroglioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Oligodendroglioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Oligodendroglioma market size from 2019 to 2032, segmented…
Pfizer Indian Offices in a BioBubble
Kolkata, December 2021 - “Our science holds the cure”, Pfizer believes. One of the leading World’s Premier Pharmaceutical and Biotech Corporation Company Pfizer delivers wellness, prevention, treatment, and cure to combat the most feared diseases.
Pfizer appreciated and implemented this revolutionary idea of disinfection by Chemtex, going by the name of BioBubble. Pfizer, a research-based global biopharmaceutical company has taken steps to protect their high foot traffic points and potential hotspots…
Pediatric Vaccines Market is demanded globally by Key Players Merck & Co. Inc., …
This detailed market study covers Pediatric Vaccines Market growth potentials which can assist the stake holders to understand key trends and prospects in Pediatric Vaccines market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
Global Pentostatin Market 2019 Scenario of Top Sellers: • Hospira (Pfizer),• …
The "Pentostatin market" study formulated by Up Market Research, presents a detailed analysis of the influential trends prevailing in this business sphere. This research report also offers definitive information concerning the commercialization of this vertical, market size, and revenue estimation of this industry. The study explicitly illustrates the competitive standing of key players over the projected timeline while incorporating their individual portfolios & geographical expansion.
The Global Pentostatin market 2019…
Migraine Drugs Market Research Exclusive Report 2019-2025 | Top Key Players Alle …
UpMarketResearch offers a latest published report on “Global Migraine Drugs Market Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 123 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/46396
Migraine Drugs Market research report delivers…
Pentostatin Market Research Report Global Forecast 2018-25 Estimated with Top Ke …
UpMarketResearch published an exclusive report on “Pentostatin market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 116 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Pentostatin market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the…